Biltmore Family Office, LLC
Family OfficePosition in CELU — Celularity Inc
CIK 1731123
CHARLOTTE, NC
Position in CELU
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,930
-$25,620 QoQ
Shares Held
35,000
0.0% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 39 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Biltmore Family Office, LLC holds $63,930 across 2 Biotechnology names. CELU ranks #2 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRTX |
Heron Therapeutics, Inc. /De/
|
100,000 | $43,000 | |
| 2 | CELU |
Celularity Inc
This page
|
35,000 | $20,930 |
All Filings in CELU
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,930 | 35,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $46,550 | 35,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $38,850 | 35,000 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $72,450 | 35,000 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $68,600 | 35,000 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $60,550 | 35,000 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $72,800 | 35,000 | Shares | Sole | 2025-02-12 | |
| 2023-12-31 | $87,685 | 355,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $81,030 | 365,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $194,545 | 365,000 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $226,300 | 365,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $146,415 | 113,500 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $128,898 | 55,800 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $73,100 | 21,500 | Shares | Sole | 2022-08-04 | |
| No filing history on record for this holder in this stock. | ||||||